Tele-Heme/Onc Services
AmplifyMD’s Tele Hematology/Oncology services connect hospitals with board-certified hematologist-oncologists, providing expert support for the identification, treatment, and management of benign and malignant blood disorders, blood cancers, solid tumors, and other types of cancer. As the demand for remote heme/onc care grows, our virtual solutions help hospitals and clinics expand access, improve patient outcomes, and manage complex cases locally.
Hospitals of all sizes can benefit from AmplifyMD’s Tele-Heme/Onc programs, designed to deliver high-quality specialty care while integrating seamlessly into existing workflows. Our specialists collaborate directly with hospital providers to support facility-specific needs and enhance the continuity of care.
Tele-Heme/Onc specialists provide expert guidance on blood disorders and cancer care virtually, assisting local providers with complex cases and treatment plans
Our Tele-Heme/Onc services include:
Hospitals benefit from expertise and support with patient needs, including:
- Management of blood disorders and clotting conditions
- Anticoagulation management or reversals
- Solid tumor treatment planning and chemotherapy management
- Oncology emergencies
- Coordination of inpatient heme/onc care
- Pre-op hematology clearance/management
- Palliative care and end-of-life discussions
Request information
Our impact
400+
Active programs
50
State footprint
220,000+
Consults annually
Tele-Heme/Onc frequently asked questions
Tele Hematology/Oncology, or Tele-Heme/Onc, uses telemedicine technology to connect hospitals with board-certified hematologist-oncologists, providing expert support for the identification, treatment, and management of benign and malignant blood disorders, blood cancers, solid tumors, and other types of cancer. These services ensure patients receive timely, specialized care across inpatient and outpatient settings.
Tele-Heme/Onc specialists provide expert care for a wide range of hematology/oncology conditions, addressing both nonmalignant and malignant cases.
Common reasons for inpatient consults include:
Nonmalignant hematology:
- Sickle cell disease
- Blood disorders (e.g., ITP)
- Clotting disorders (e.g., DVT/PE)
- Abnormal blood counts (e.g., anemia, low platelets, myeloproliferative disorders)
- Bleeding issues, including intracranial hemorrhage (ICH)
- Anticoagulant management or reversal
- Pre-operative hematology clearance or management
Malignant hematology:
- Suspected or confirmed leukemia, lymphoma, or multiple myeloma
- Myelodysplastic syndromes
Solid tumor oncology:
- Oncology emergencies
- New cancer diagnoses
- Treatment planning
- Chemotherapy management
Palliative care and end-of-life-discussions
Each implementation timeline will vary, but AmplifyMD’s Tele-Heme/Onc programs are designed to have a short implementation window, potentially going live in as little as a few weeks.
AmplifyMD is a hardware-agnostic platform that allows hospitals to choose the technology that best suits their needs. Our customers use a variety of hardware configurations for Tele Hematology/Oncology – from free-standing traditional telehealth carts to Smart TVs to tablets and PCs.
Yes. Many health systems use the AmplifyMD virtual care platform to optimize hematology/oncology services with their own network of hematology oncologists. AmplifyMD’s platform helps standardize quality outcomes and improves hub-and-spoke Tele Hematology/Oncology efficiencies.